Vimian Group AB (publ) (OTCMKTS:VIMGF) Short Interest Down 16.4% in December

Vimian Group AB (publ) (OTCMKTS:VIMGF) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 65,900 shares, a decrease of 16.4% from the November 30th total of 78,800 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ? days.

Vimian Group AB (publ) Stock Up 7.3 %

Shares of VIMGF opened at C$3.89 on Tuesday. Vimian Group AB has a 52-week low of C$2.68 and a 52-week high of C$4.12. The stock has a 50 day moving average price of C$3.63 and a 200 day moving average price of C$3.44.

Vimian Group AB (publ) Company Profile

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.